Donor cell-derived sarcoidosis after allogeneic BMT.
Morita
R
R
Hashino
S
S
Kubota
K
K
Onozawa
M
M
Kahata
K
K
Kondo
T
T
Suzuki
S
S
Matsuno
Y
Y
Imamura
M
M
Asaka
M
M
D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000494:pharmacology; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008224:Lymphoma, Follicular / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000494:pharmacology; D012074:Remission Induction; D012507:Sarcoidosis / Q000209:etiology*; D014184:Transplantation, Homologous / Q000009:adverse effects*; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18